W. D. Ludwig

3.2k total citations
48 papers, 2.0k citations indexed

About

W. D. Ludwig is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, W. D. Ludwig has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 24 papers in Public Health, Environmental and Occupational Health and 10 papers in Molecular Biology. Recurrent topics in W. D. Ludwig's work include Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (24 papers) and Chronic Myeloid Leukemia Treatments (10 papers). W. D. Ludwig is often cited by papers focused on Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (24 papers) and Chronic Myeloid Leukemia Treatments (10 papers). W. D. Ludwig collaborates with scholars based in Germany, Italy and United States. W. D. Ludwig's co-authors include Brigitte Royer‐Pokora, Jürgen Finke, Valérie Gouilleux‐Gruart, Wolfgang Hiddemann, Roland Mertelsmann, Hans G. Drexler, E. Thiel, Th. Büchner, Heiko Rühl and R. Kuse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

W. D. Ludwig

48 papers receiving 1.9k citations

Peers

Countries citing papers authored by W. D. Ludwig

Since Specialization

Citations

This map shows the geographic impact of W. D. Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. D. Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. D. Ludwig more than expected).

Fields of papers citing papers by W. D. Ludwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. D. Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. D. Ludwig. The network helps show where W. D. Ludwig may publish in the future.

Co-authorship network of co-authors of W. D. Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of W. D. Ludwig. A scholar is included among the top collaborators of W. D. Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. D. Ludwig. W. D. Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol 2013 ·Haematologica ·(unknown), Peter Rhein, (unknown), Martin Zimmermann, Obul Reddy Bandapalli, (unknown), Anja Moericke, W. D. Ludwig, Richard Ratei, Martina U. Muckenthaler, Andreas E. Kulozik, (unknown), M. Stanulla, Leonid Karawajew	24
2	Q-Fieber-Epidemie in Berlin: Epidemiologische und klinische Aspekte 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Thomas Schneider, H Jahn, (unknown), (unknown), Oliver Liesenfeld, (unknown), (unknown), Holger N. Lode, W. D. Ludwig, (unknown), M Zeitz, E. O. Riecken	9
3	Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection?case report and review of the literature 2004 ·Annals of Hematology ·Jean‐François Bergmann, Claudia Schoch, W. D. Ludwig, Andreas Reiter, Jan Hastka, Eva Lengfelder, R. Hehlmann, Ole Maywald, Dieter Buchheidt	51
4	Need for Safety Goggles for Endoscopy 2003 ·Endoscopy ·T. Benter, (unknown), Ulf Teichgräber, (unknown), W. D. Ludwig, Bernd Dörken	6
5	Akute lymphatische Leukämie des Erwachsenen Diagnostik, Risikogruppen und Therapie 2002 ·Der Internist ·(unknown), D. Hoelzer, R. Arnold, C. R. Bartram, (unknown), M. Freund, (unknown), Michael Kneba, (unknown), W. D. Ludwig, Georg Maschmeyer, (unknown), E. Thiel, (unknown), (unknown), Nicola Gökbuget	2
6	Short Communication : Sequence Analysis of the First HTLV-I Infection in Germany without Relations to Endemic Areas 1998 ·AIDS Research and Human Retroviruses ·(unknown), C. Fleischer, Marco Salemi, Peter Reinhardt, W. D. Ludwig, Anne–Mieke Vandamme, Georg Pauli	17
7	Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia 1998 ·Annals of Hematology ·Richard Ratei, Christian Sperling, Leonid Karawajew, Gisela Schott, Martin Schrappe, Jochen Harbott, H. Riehm, W. D. Ludwig	49
8	Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups. 1997 ·Journal of Clinical Oncology ·Valentino Conter, Martin Schrappe, Maurizio Aricò, Alfred Reiter, Carmelo Rizzari, Michael Dördelmann, M. G. Valsecchi, M Zimmermann, W. D. Ludwig, Giuseppe Basso, Giuseppe Masera, H. Riehm	54
9	Einsatz der Ga-67-SPECT bei Patienten mit malignen Lymphomen nach primärer Chemotherapie für die weitere Therapieplanung: Vergleich mit einem Spiral-CT 1997 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Christian Stroszczynski, Holger Amthauer, Norbert Hosten, MY Mapara, Jens Ricke, (unknown), (unknown), W. D. Ludwig, H. Eichstädt, R Felix	5
10	GM-CSF Multiple Course Priming and Long-Term Administration in Newly Diagnosed Acute Myeloid Leukemia: Comparison of Three Different GM-CSF Routes and Schedules with No GM-CSF 1994 ·Oncology Research and Treatment ·(unknown), Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann, Georg Maschmeyer, W. D. Ludwig, M. Zühlsdorf	4
11	Incidence and Prognostic Significance of Immunophenotypic Subgroups in Childhood Acute Lymphoblastic Leukemia: Experience of the BFM Study 86 1993 ·Recent results in cancer research ·W. D. Ludwig, Jochen Harbott, CR Bartram, (unknown), Christian Sperling, (unknown), (unknown), Michael Notter, E. Odenwald, (unknown), E. Thiel, H. Riehm	38
12	High-Dose Versus Intermediate Dose Cytosine Arabinoside Combined with Mitoxantrone for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia: Results of an Age Adjusted Randomized Comparison 1993 ·Leukemia & lymphoma ·Wolfgang Hiddemann, Carlo Aul, Georg Maschmeyer, (unknown), W. D. Ludwig, A. Bartholomäus, Peter Bettelheim, Katja Becker, Leopold Balleisen, B. Lathan, H. Köppler, (unknown), (unknown), Albrecht Reichle, Achim Heinecke, Cristina Sauerland, Th. Büchner	25
13	Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. 1993 ·PubMed ·Hans G. Drexler, E. Thiel, W. D. Ludwig	91
14	Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. 1992 ·PubMed ·W. E. Berdel, Sven de Vos, J. Mäurer, D Oberberg, (unknown), (unknown), Jin Li, W. D. Ludwig, E.D. Kreuser, (unknown)	45
15	Acute megakaryoblastic leukemia a comparison of phenotypic genotypic and clinical features in children and adults 1991 ·Ursula Köller, O. A. Haas, W. D. Ludwig, Jochen Harbott, U. Creutzig, Peter Bettelheim, O. Krieger, H. Gadner, (unknown)	1
16	Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo 1991 ·Leukemia & lymphoma ·(unknown), W. D. Ludwig, E. Thiel	1
17	Clinical Importance of T-ALL Subclassification According to Thymic or Prethymic Maturation Stage 1990 ·Hämatologie und Bluttransfusion ·W. D. Ludwig, E. Thiel, Claus R. Bartram, (unknown), A. Raghavachar, H. Löffler, Arnold Ganser, Thomas Büchner, Wolfgang Hiddemann, Gerhard Heil, M. Freund, Georg Maschmeyer, (unknown), D. Messerer, H. Riehm, D. Hoelzer	9
18	Inzidenz, klinische Merkmale und prognostische Bedeutung immunologischer Subtypen der akuten lymphoblastischen Leukämie (ALL) im Kindesalter: Erfahrungen der Therapiestudien ALL-BFM 83 und 86 1990 ·Klinische Pädiatrie ·W. D. Ludwig, (unknown), Christian Sperling, (unknown), J. Ritter, Alfred Reiter, E. Odenwald, S. Sauter, H. Riehm	13
19	Clinicopathological Features and Prognostic Implications of Immunophenotypic Subgroups in Childhood ALL: Experience of the BFM-ALL Study 83 1989 ·Hämatologie und Bluttransfusion ·W. D. Ludwig, (unknown), (unknown), (unknown), (unknown), George Gassner, E. Odenwald, Jan Hofmann, H. Riehm	6
20	High-Dose Cytosine-Arabinoside and Mitoxantrone in Refractory Acute Myeloid Leukemia: A Clinical Phase I/II-Study 1986 ·Oncology Research and Treatment ·Wolfgang Hiddemann, (unknown), Kurt Straíf, W. D. Ludwig, (unknown), Eva Lengfelder, (unknown), Thomas Büchner	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact